FDA lists Class II recall of Nalu therapy discs over a firmware failure
Boston Scientific's recall covers 134 units of the therapy disc used with the Nalu neurostimulation system. A failed disc can leave the implant unable to deliver therapy if no backup is available.
The FDA has classified a recall of Nalu TD2 Therapy Discs as Class II, according to an entry posted on October 29. Boston Scientific Neuromodulation began the recall on September 30. It covers 134 units distributed in the US, including discs and patient kits with firmware versions 2.0.71 and 2.0.77. The firmware can attempt a restart, fail and leave the disc nonfunctional.
If no backup disc is on hand, the implanted pulse generator may also stop working, so it can’t block pain signals. The FDA lists the cause as software change control, and the recall remains open. Boston Scientific bought Nalu earlier, and the recall sits under its neuromodulation unit in Valencia, California.
Learn more: Boston Scientific Neuromodulation · Nalu Medical